Wolff Financial Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.32M Sell
7,772
-425
-5% -$434K 1.86% 12
2026
Q1
$7.54M Buy
8,197
+1
+0% +$1.01K 1.67% 12
2025
Q4
$8.81M Hold
8,196
1.98% 12
2025
Q3
$6.25M Sell
8,196
-207
-2% -$154K 1.45% 12
2025
Q2
$6.55M Sell
8,403
-402
-5% -$312K 1.69% 11
2025
Q1
$7.27M Hold
8,805
2.01% 11
2024
Q4
$6.8M Sell
8,805
-224
-2% -$185K 1.89% 11
2024
Q3
$8M Buy
+9,029
New +$8.12M 2.17% 11
2024
Q2
Sell
-9,029
Closed -$7.02M 65
2024
Q1
$7.02M Sell
9,029
-5,808
-39% -$4.13M 2.05% 11
2023
Q4
$8.65M Buy
14,837
+1
+0% +$584 2.67% 10
2023
Q3
$7.97M Buy
+14,836
New +$7.64M 2.72% 10
2023
Q2
Sell
-15,128
Closed -$5.2M 67
2023
Q1
$5.2M Buy
15,128
+1
+0% +$337 1.81% 13
2022
Q4
$5.53M Sell
15,127
-17
-0.1% -$6.03K 2.05% 13
2022
Q3
$4.9M Buy
15,144
+1
+0% +$317 2.23% 14
2022
Q2
$4.91M Buy
15,143
+1,815
+14% +$545K 2.18% 14
2022
Q1
$3.82M Buy
13,328
+1
+0% +$257 1.52% 16
2021
Q4
$3.68M Buy
+13,327
New +$3.38M 1.39% 16
2021
Q1
$2.63M Sell
14,081
-411
-3% -$80.4K 1.21% 21
2020
Q4
$2.45M Sell
14,492
-191
-1% -$28.5K 1.28% 21
2020
Q3
$2.17M Buy
14,683
+2
+0% +$310 1.29% 19
2020
Q2
$2.41M Buy
14,681
+2
+0% +$307 1.53% 17
2020
Q1
$2.04M Buy
14,679
+415
+3% +$57K 1.54% 16
2019
Q4
$1.88M Sell
14,264
-83
-0.6% -$9.62K 1.24% 18
2019
Q3
$1.6M Buy
14,347
+2
+0% +$223 1.17% 20
2019
Q2
$1.59M Buy
14,345
+2
+0% +$236 1.22% 18
2019
Q1
$1.86M Buy
14,343
+368
+3% +$44.7K 1.54% 15
2018
Q4
$1.62M Buy
+13,975
New +$1.56M 1.57% 14

Other funds holding LLY

Wolff Financial Management's LLY Position: Q2 2026 in Review

Wolff Financial Management reduced its Eli Lilly (LLY) stake by 5.2% in Q2 2026, selling an estimated $434K and leaving 7,772 shares worth $9.32M. The position accounts for 1.86% of the portfolio, ranked #12.

Wolff Financial Management first reported a position in LLY in Q4 2018 and has held it in 27 quarters since. 1,098 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wolff Financial Management held 7,772 shares of Eli Lilly worth $9.32M as of Q2 2026.
  • Wolff Financial Management sold 425 Eli Lilly shares in Q2 2026, an estimated $434K.
  • Eli Lilly made up 1.86% of Wolff Financial Management's portfolio in Q2 2026, its #12 holding.
  • Wolff Financial Management first reported a position in Eli Lilly in Q4 2018 and has held it in 27 quarters since.
  • 1,098 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wolff Financial Management's 13F filing for Q2 2026, filed 16 Jul 2026.